Patients now interact with AI chatbots to renew prescriptions without real-time physician evaluation, with the system assessing drug interactions and appropriateness based on patient history and current status.
This move aims to reduce administrative burdens and expand access, but raises concerns over transparency, liability, and potential economic biases embedded in AI-driven decisions, especially as startups rapidly expand such workflows.
The Utah Medical Licensing Board previously called for suspension of the AI program due to patient safety concerns, highlighting unresolved legal, regulatory, and ethical challenges as AI increasingly replaces human clinical judgment.
Will Utah's AI experiment set a national precedent or will other states ban it?
How can Utah's AI doctor program guarantee patient safety against AI 'hallucinations'?
Can new federal AI laws prevent a chaotic patchwork of state healthcare regulations?
How is patient data protected when a private AI company handles prescription renewals?
When an AI renews a prescription that causes harm, who is legally held accountable?